Home
About
Services
Partners
Client Portfolio
News
Contact
VW may sideline Audi, link with rivals in new 10-year plan
November 2, 2018
U.S. SEC collects nearly $4 billion in fines, disgorgement in fiscal 2018
November 2, 2018
0
AbbVie sees hit to Humira sales from European competition
Published by
Muller&Green
at
November 2, 2018
Categories
RSS
Tags
U.S. drugmaker AbbVie Inc on Friday lowered its overseas sales forecast for its top-selling medicine, Humira, as it agreed to larger-than-expected price cuts due to new European competition.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more